Synartro AB
Developing sustained local injection treatments for osteoarthritis pain relief.
Yleiskatsaus
- 1–4
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Magnus Hurst
CFO & acting CEO
Antonio Bermejo Gómez
Chief Development Officer
Mats Persson
Board Member
Maria Nyhage
Board Member
+2 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Synartro AB is a clinical stage Swedish life science company focused on developing novel local injection treatments for osteoarthritis (OA). Their core innovation lies in a patented technology that chemically binds existing, proven drugs to a base compound. This process enables sustained drug releas...